Androgen Receptor Mutations in Carcinoma of the Prostate: Significance for Endocrine Therapy

Author： Culig Z.   Klocker H.   Bartsch G.   Hobisch A.  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.1, Iss.4, 2001-01, pp. : 241-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Intracrine Androgen Metabolism, Androgen Receptor and Apoptosis in the Survival and Recurrence of Prostate Cancer During Androgen Deprivation Therapy

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 420-440

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A   Golijanin Dragan J   Miyamoto Hiroshi   Messing Edward M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite

Antiandrogens in Prostate Cancer Endocrine Therapy

By  

Current Cancer Drug Targets, Vol. 4, Iss. 5, 2004-08 ,pp. : 455-461

Bentham Science Publishers

Access to resources Recommend Favorite

The androgen receptor as a therapeutic target in prostate cancer

By Visakorpi T.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 65-71

Informa Healthcare

Access to resources Recommend Favorite

Androgen Receptor Antagonists in the Treatment of Prostate Cancer

By  

Clinical Immunology, Endocrine & Metabolic Drugs, Vol. 1, Iss. 1, 2014-06 ,pp. : 11-19

Bentham Science Publishers

Access to resources Recommend Favorite